A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease
Clinical trial NCT00736775 · COMPLETED
Trial details
- NCT number
- NCT00736775
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-05-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.